FDA approves first implant to treat rheumatoid arthritis

Hurricanelover

Diamond Member
Joined
Oct 4, 2021
Messages
3,949
Reaction score
4,449
Points
1,938
FDA approves first implant to treat rheumatoid arthritis
By Bronwyn Thompson
August 26, 2025
The first-ever neuroimmune modulation implant has been approved for people with moderate to severe rheumatoid arthritis (RA) who haven't found relief with traditional medications. It's a potentially life-changing technology that can zap pain by delivering one-minute electrical pulses to the vagus nerve – a key neural pathway that regulates inflammation.

The US Food and Drug Administration (FDA) has greenlit the device developed by California's SetPoint Medical, based on positive outcomes from the RESET‑RA clinical trial – a 242-patient, randomized, double-blind, sham-controlled study. It showed measurable improvements in disease activity by three months, with sustained benefits at 12 months. Impressively, 75% of participants were using just the implant and no other therapeutics after just 12 months.

We covered earlier trial stages of the device, which is about the size of a vitamin or coffee bean, back in 2021. However, the SetPoint System has been in development for two decades.


This is painful and I've seen people suffer from this. I am glad to see another way for them to stop their pain.
 
Back
Top Bottom